Filing Details
- Accession Number:
- 0001179110-14-003190
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-20 15:43:22
- Reporting Period:
- 2014-02-18
- Filing Date:
- 2014-02-20
- Accepted Time:
- 2014-02-20 15:43:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1308911 | E John Bishop | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | Senior Vp, Pharmaceutical Scie | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-18 | 19,312 | $0.00 | 113,092 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2014-02-19 | 216 | $17.86 | 112,876 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-02-19 | 217 | $17.86 | 112,659 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2014-02-18 | 38,575 | $17.96 | 38,575 | $17.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 185,946 | 2014-05-18 | 2024-02-18 | No | 4 | A | Direct |
Footnotes
- Represents 19,312 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, and subject to a restricted stock agreement to be entered between the Company and Mr. Bishop. Pursuant to the restricted stock agreement, 25% of the shares of restricted Common Stock shall vest on February 18, 2015 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter.
- Represents an option granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria, the shares subject to such option vest as to 6.25% of the shares at the end of each three-month period following the grant date.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2009.
Billionaire Hedge Funds
